サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：寒冷凝集素症の世界市場（2022年～2028年）：薬剤別、剤形別、エンドユーザー別、地域別の市場規模調査と予測
市場調査レポート
商品コード
1084060

寒冷凝集素症の世界市場（2022年～2028年）：薬剤別、剤形別、エンドユーザー別、地域別の市場規模調査と予測

Global Cold Agglutinin Disease Market Size study, By Drugs, By Dosage Form, By End-Users, and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
寒冷凝集素症の世界市場（2022年～2028年）：薬剤別、剤形別、エンドユーザー別、地域別の市場規模調査と予測
出版日: 2022年05月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の寒冷凝集素症の市場規模は、2022年～2028年の予測期間中に健全な成長率で成長すると予想されています。市場を牽引する主な要因には、高齢者の増加、寒冷凝集素症の発生率の上昇、医療費の増加などがあります。しかし、新興国では熟練した専門家の不足や医療インフラの不足が、予測期間における市場の成長を阻害しています。また、医薬品の承認・上市数の増加や先端技術開発への投資拡大が、予測期間中の市場需要の触媒として作用すると予測されます。

当レポートでは世界の寒冷凝集素症市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の寒冷凝集素症市場：定義と範囲

第3章 世界の寒冷凝集素症：市場力学

  • 寒冷凝集素症市場：影響分析（2020年～2028年）

第4章 世界の寒冷凝集素症市場：業界分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界の寒冷凝集素症市場：薬剤別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • コルチコステロイド
    • アルキル化剤
    • プリンヌクレオシド類似体
    • 生物製剤
    • その他

第7章 世界の寒冷凝集素症市場：剤形別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 錠剤
    • 注射
    • その他

第8章 世界の寒冷凝集素症市場：エンドユーザー別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 病院
    • 専門診療所
    • 在宅医療
    • その他

第9章 世界の寒冷凝集素症市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情勢

  • 主な市場戦略
  • 企業プロファイル
    • Sanofi
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Zydus Cadila
    • AstraZeneca
    • Johnson & Johnson
    • Bayer AG
    • Sun Pharmaceutical Industries Ltd.
    • Apellis Pharmaceuticals

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Cold Agglutinin Disease Market, report scope
  • TABLE 2. Global Cold Agglutinin Disease Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Cold Agglutinin Disease Market estimates & forecasts by Drugs 2018-2028 (USD Million)
  • TABLE 4. Global Cold Agglutinin Disease Market estimates & forecasts by Dosage form 2018-2028 (USD Million)
  • TABLE 5. Global Cold Agglutinin Disease Market estimates & forecasts by End-Users 2018-2028 (USD Million)
  • TABLE 6. Global Cold Agglutinin Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Cold Agglutinin Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Cold Agglutinin Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Cold Agglutinin Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Cold Agglutinin Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Cold Agglutinin Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Cold Agglutinin Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Cold Agglutinin Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Cold Agglutinin Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Cold Agglutinin Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. U.S. Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. Canada Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 20. Canada Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. Canada Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. UK Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 23. UK Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. UK Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. Germany Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 26. Germany Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. Germany Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. RoE Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 29. RoE Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. RoE Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. China Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 32. China Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. China Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. India Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 35. India Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. India Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. Japan Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 38. Japan Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. Japan Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. Brazil Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 44. Brazil Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Brazil Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Mexico Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 47. Mexico Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. Mexico Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. RoLA Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 50. RoLA Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. RoLA Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. Row Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 53. Row Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. Row Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. List of secondary sources, used in the study of global Cold Agglutinin Disease Market
  • TABLE 56. List of primary sources, used in the study of global Cold Agglutinin Disease Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Cold Agglutinin Disease Market, research methodology
  • FIG 2. Global Cold Agglutinin Disease Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Cold Agglutinin Disease Market, key trends 2021
  • FIG 5. Global Cold Agglutinin Disease Market, growth prospects 2022-2028
  • FIG 6. Global Cold Agglutinin Disease Market, porters 5 force model
  • FIG 7. Global Cold Agglutinin Disease Market, pest analysis
  • FIG 8. Global Cold Agglutinin Disease Market, value chain analysis
  • FIG 9. Global Cold Agglutinin Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Cold Agglutinin Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Cold Agglutinin Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Cold Agglutinin Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Cold Agglutinin Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Cold Agglutinin Disease Market, regional snapshot 2018 & 2028
  • FIG 15. North America Cold Agglutinin Disease Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Cold Agglutinin Disease Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Cold Agglutinin Disease market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Cold Agglutinin Disease Market 2018 & 2028 (USD Million)
  • FIG 19. Global Cold Agglutinin Disease Market, company market share analysis (2021)
目次

Global Cold Agglutinin Disease Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Cold agglutinin disease (CAD) is a variety of autoimmune hemolytic anemia (AIHA). In this condition, the individual's immune system attacks and destroys their own red blood cells (RBCs) because of the higher exposure to cold temperatures. The increasing number of geriatric people, rising incidences of cold agglutinin disease, and growing healthcare expenditure are major factors fueling the market demand across the globe. For instance, according to the Department of Economic and Social Affairs, in 2019, the world's population of people aged 65 and up totaled 703 million. Also, the number of elderly people is expected to increase to 1.5 billion by 2050. Accordingly, the increasing number of aged people are more likely to suffer from Cold Agglutinin Disease, which, in turn, bolsters the growth of the global market. However, the shortage of skilled professionals and lack of healthcare infrastructure in emerging regions impede the growth of the market over the forecast period of 2022-2028. Also, an increase in the number of drug approvals and launches and growing investment in the development of advanced technologies are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Cold Agglutinin Disease Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing healthcare expenditure, the presence of various prominent market players, and growing investment in R&D activities. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing patient pool, as well as availability of better healthcare facilities, would create lucrative growth prospects for the Cold Agglutinin Disease Market across the Asia-Pacific region.

Major market players included in this report are:

Sanofi

Pfizer Inc.

GlaxoSmithKline plc

Novartis AG

Zydus Cadila

AstraZeneca

Johnson & Johnson

Bayer AG

Sun Pharmaceutical Industries Ltd.

Apellis Pharmaceuticals

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drugs:

Corticosteroids

Alkylating Agents

Purine Nucleoside Analogs

Biologics

Others

By Dosage Form:

Tablets

Injections

Others

By End-Users:

Hospitals

Specialty Clinics

Homecare

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Cold Agglutinin Disease Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Cold Agglutinin Disease Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Cold Agglutinin Disease Market, by Drugs, 2020-2028 (USD Million)
    • 1.2.3. Cold Agglutinin Disease Market, by Dosage Form, 2020-2028 (USD Million)
    • 1.2.4. Cold Agglutinin Disease Market, by End-Users, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cold Agglutinin Disease Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cold Agglutinin Disease Market Dynamics

  • 3.1. Cold Agglutinin Disease Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing number of geriatric people
      • 3.1.1.2. Rising incidences of cold agglutinin disease
    • 3.1.2. Market Challenges
      • 3.1.2.1. Shortage of skilled professionals
      • 3.1.2.2. Lack of healthcare infrastructure in emerging regions
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in number of drug approvals and launches
      • 3.1.3.2. Growing investment in development of advanced technologies

Chapter 4. Global Cold Agglutinin Disease Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Cold Agglutinin Disease Market, by Drugs

  • 6.1. Market Snapshot
  • 6.2. Global Cold Agglutinin Disease Market by Drugs, Performance - Potential Analysis
  • 6.3. Global Cold Agglutinin Disease Market Estimates & Forecasts by Drugs, 2018-2028 (USD Million)
  • 6.4. Cold Agglutinin Disease Market, Sub Segment Analysis
    • 6.4.1. Corticosteroids
    • 6.4.2. Alkylating Agents
    • 6.4.3. Purine Nucleoside Analogs
    • 6.4.4. Biologics
    • 6.4.5. Others

Chapter 7. Global Cold Agglutinin Disease Market, by Dosage Form

  • 7.1. Market Snapshot
  • 7.2. Global Cold Agglutinin Disease Market by Dosage form, Performance - Potential Analysis
  • 7.3. Global Cold Agglutinin Disease Market Estimates & Forecasts by Dosage form, 2018-2028 (USD Million)
  • 7.4. Cold Agglutinin Disease Market, Sub Segment Analysis
    • 7.4.1. Tablets
    • 7.4.2. Injections
    • 7.4.3. Others

Chapter 8. Global Cold Agglutinin Disease Market, by End-Users

  • 8.1. Market Snapshot
  • 8.2. Global Cold Agglutinin Disease Market by End-Users, Performance - Potential Analysis
  • 8.3. Global Cold Agglutinin Disease Market Estimates & Forecasts by End-Users, 2018-2028 (USD Million)
  • 8.4. Cold Agglutinin Disease Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Specialty Clinics
    • 8.4.3. Homecare
    • 8.4.4. Others

Chapter 9. Global Cold Agglutinin Disease Market, Regional Analysis

  • 9.1. Cold Agglutinin Disease Market, Regional Market Snapshot
  • 9.2. North America Cold Agglutinin Disease Market
    • 9.2.1. U.S. Cold Agglutinin Disease Market
      • 9.2.1.1. Drugs breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Dosage form breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. End-Users breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Cold Agglutinin Disease Market
  • 9.3. Europe Cold Agglutinin Disease Market Snapshot
    • 9.3.1. U.K. Cold Agglutinin Disease Market
    • 9.3.2. Germany Cold Agglutinin Disease Market
    • 9.3.3. France Cold Agglutinin Disease Market
    • 9.3.4. Spain Cold Agglutinin Disease Market
    • 9.3.5. Italy Cold Agglutinin Disease Market
    • 9.3.6. Rest of Europe Cold Agglutinin Disease Market
  • 9.4. Asia-Pacific Cold Agglutinin Disease Market Snapshot
    • 9.4.1. China Cold Agglutinin Disease Market
    • 9.4.2. India Cold Agglutinin Disease Market
    • 9.4.3. Japan Cold Agglutinin Disease Market
    • 9.4.4. Australia Cold Agglutinin Disease Market
    • 9.4.5. South Korea Cold Agglutinin Disease Market
    • 9.4.6. Rest of Asia Pacific Cold Agglutinin Disease Market
  • 9.5. Latin America Cold Agglutinin Disease Market Snapshot
    • 9.5.1. Brazil Cold Agglutinin Disease Market
    • 9.5.2. Mexico Cold Agglutinin Disease Market
  • 9.6. Rest of The World Cold Agglutinin Disease Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Sanofi
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Pfizer Inc.
    • 10.2.3. GlaxoSmithKline plc
    • 10.2.4. Novartis AG
    • 10.2.5. Zydus Cadila
    • 10.2.6. AstraZeneca
    • 10.2.7. Johnson & Johnson
    • 10.2.8. Bayer AG
    • 10.2.9. Sun Pharmaceutical Industries Ltd.
    • 10.2.10. Apellis Pharmaceuticals

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption